Programme
SESSION 11.00pm to 2.05pm
Updates in COVID-19 Vaccination Strategies and Outcomes
Dr Loh Jiashen
Infectious Disease Physician
MBBS (NUS, Singapore),
FAMS

Dr Loh Jiashen

Infectious Disease Physician

MBBS (NUS, Singapore),
FAMS

Profile

Dr Loh Jiashen graduated in 2007 and has spent 13 years in public service. He completed his infectious diseases advanced training in Tan Tock Seng Hospital and Communicable Disease Centre (CDC), now renamed the National Centre of Infectious Disease. In that time, he was exposed to a wide breadth of conditions through his rotations through National University Hospital and Singapore General Hospital. Upon completing his training in 2016, his first appointment was to set up the infectious disease service in the then upcoming Seng Kang General Hospital. In that time, he helmed the Antibiotic Stewardship program, HIV program, held positions in national committees and supported various specialty services in their early days of growth and now in their daily infectious diseases related issues.

Throughout his time in institutional practice, he has always valued patient care above all else. As new colleagues join and the fight against COVID draws to a pause, he enters private practice in January 2021 to focus more on patient care.

Abstract

COVID-19 vaccinations have started in varying pace across the globe. Vaccine options and schedules are equally varied. Early data seems to demonstrate real life efficacy that are reflected in clinical trials, providing hope for an end to the COVID-19 pandemic. This short talk informs on some recent COVID-19 vaccine trends, strategies, efficacy, safety outcomes and local recommendations.

The COVID-19 Infection and Venous Thromboembolism
Dr Ng Chin Hin
Haematologist
MD (Malaysia),
MRCP (UK),
FRCPATH (UK),
MCI (Singapore),
FAMS (Haem)

Dr Ng Chin Hin

Haematologist

MD (Malaysia),
MRCP (UK),
FRCPATH (UK),
MCI (Singapore),
FAMS (Haem)

Profile

Dr Ng Chin Hin is a consultant haematologist based in Gleneagles Hospital. Prior to joining Gleneagles Hospital, Dr Ng was the leukaemia lead at National University Cancer Institute of Singapore (NCIS) and has more than 10 years of experience in this field. He is a local and regional key opinion leader in the management of leukemia and myeloproliferative neoplasm. He was active in clinical research and was the research director for the haematology division in the Department of Haematology-Oncology at NCIS. He was also an assistant professor in the Department of Medicine in NUS and was actively involved in the undergraduates training.

He specialises in the treatment of leukaemia. Besides, he also treats a wide range of both benign and malignant haematological conditions. Dr Ng is passionate about improving the outcome of acute leukaemia by means of MRD-guided therapy and optimising the use of novel targeted therapy. He firmly believes that MRD-guided treatment of acute Leukaemia in combination with novel targeted therapy provides optimum treatment outcome and minimises unnecessary toxicity.

Abstract

COVID-19 pandemic represents an unprecedented threat to global health care systems with more than 15 millions cases and over 2.5 millions deaths worldwide as of 2nd March 2021. The severity of COVID-19 infection varies between patients ranging from mild respiratory disease to acute respiratory distress syndrome, shock, and multi-organ failure associated with an increased risk of death.

The clinical course of COVID-19 is often accompanied by a hyperinflammatory response and systemic coagulation derangement, which may evolve into overt disseminated intravascular coagulopathy and increase the risk of venous thromboembolism (VTE). In this short talk, I would share with you the incidence of VTE, the underlying pathophysiology and the current recommendation for management and prevention of VTE in COVID-19 patients.

Updates in Fatty Liver Management
Dr Kenneth Koo
Gastroenterologist
MBBS (NUS, Singapore),
MMed (Int Med) (NUS, Singapore),
MRCP (UK) (RCP, United Kingdom),
FRCPEd (RCP, Edinburgh, United Kingdom)

Dr Kenneth Koo

Gastroenterologist

MBBS (NUS, Singapore),
MMed (Int Med) (NUS, Singapore),
MRCP (UK) (RCP, United Kingdom),
FRCPEd (RCP, Edinburgh, United Kingdom)

Profile

Dr Kenneth Koo is a Gastroenterologist practising in Gleneagles Hospital. Prior to commencing private practise, Dr Koo was Director of Gastroenterology at Ng Teng Fong General Hospital and was an integral member of the team which set up the unit. He was also the Chair of the Endoscopy unit from 2016 till 2019 where he was responsible for the quality and governance of the endoscopy center. A keen educator, Dr Koo also served as the associate program director for NUHS Gastroenterology senior residency program from 2013 to 2018.

He manages a wide range of disorders affecting the digestive system and liver such as acid reflux, dyspepsia, irritable bowel syndrome, chronic viral hepatitis, liver cirrhosis, inflammatory bowel disease etc. In particular, he has a special interest in therapeutic gastroscopy, colonoscopy and ERCP.

Abstract

Together with the rise in metabolic diseases such as diabetes mellitus, hyperlipidaemia and obesity, the prevalence of non-alcoholic fatty liver disease (NAFLD) has increased dramatically over the past few decades. In western countries, it is estimated to affect between 17-46% of adults and in Asia 29%.

The more severe form of NAFLD ie non-alcoholic steatohepatitis (NASH) has been linked to increased mortality, with liver related mortality coming in after cardiovascular causes. Risk of Hepatocellular carcinoma has also been associated with NAFLD especially in those with advanced fibrosis or cirrhosis.

This talk aims to highlight the salient points in the assessment and management of this common condition.

Panel Q&A Discussion

Moderator

Dr John Law,

Respiratory Physician

MBBS (Melbourne),
MRCP (UK),
FCCP (USA),
FAMS (Respiratory Med)

Moderator

Dr Vivien Lim,

Endocrinologist

MBBS (Singapore),
MRCP (UK),
MMed (Internal Medicine) (Singapore),
FAMS (Endocrinology)
SESSION 22.05pm to 3.20pm
Keyboard Warriors and Working From Home – Impact on Hand Injury Patterns
Dr David Tan
Hand Surgeon
MBBS (NUS, Singapore),
MMed (Surg) (NUS, Singapore)

Dr David Tan

Hand Surgeon

MBBS (NUS, Singapore),
MMed (Surg) (NUS, Singapore)

Profile

Dr David Tan is a senior hand surgeon with Orthopaedic and Hand Surgery Partners at Gleneagles Hospital and has a broad expertise in hand, wrist, and peripheral nerve disorders. He subspecializes in wrist and elbow surgery, as well as sports injuries to the hand and wrist. His interests are in arthroscopic reconstructions of the wrist, treatment of wrist fractures and management of elbow injuries.

He graduated from the National University of Singapore in 1998, embarked on specialty training in Hand Surgery in 2005 and received his accreditation in Hand Surgery in 2008. He practiced hand surgery for twelve years in the National University Hospital. He completed a one-year ACGME accredited fellowship in Hand Surgery at the Hospital for Special Surgery in New York from 2011-2012. Upon returning from fellowship, he was appointed Program Director for the Hand Surgery Residency Program before relinquishing the position in early 2020.

Since starting private practice in April 2021, Dr Tan has continued to be engaged in the public healthcare sector as a visiting consultant hand surgeon to several restructured hospitals and spends four sessions a week divided equally between the National University Hospital and Changi General Hospital running specialist referral clinics, performing both simple and complex procedures and nurturing young surgeons. Dr Tan continues to also be actively involved in education and training in the specialty of hand surgery and is frequently invited to present and share at local, regional, and international forums as a speaker.

Abstract

With the local outbreak of the COVID-19 Pandemic in Singapore early last year, the Singapore Government enacted Safe Management Measures (SMM) to mitigate and prevent community spread and transmission of the disease. Working from home (WFH) was implemented for all businesses and organizations till early this year, where it remains the default mode for many workplaces still. This in turn has led to changes in the way individuals work, including the amount of time spent discharging their occupational duties.

The lines separating official working hours and leisure time and breaks blur in their distinction at times as a further compounding factor. Over the past year of one hand surgeon’s practice, an increasing number of upper limb complaints and symptoms amongst patients have been seen, attributable to the changes in the way these patients have been working because of necessary compliance with SMM and WFH policies. These include poor ergonomics, longer hours at the desk and/on the keyboard and the absence of regular breaks when working from home. Consequently, patients have been presenting more commonly with a constellation of symptoms typical of repetitive strain injury affecting multiple sites and often in atypical patient groups.

This presentation will focus on the most common presenting symptoms, pathologies as well as elucidating the reasons and cover the practical and medical management strategies to address this “emerging” disease pattern.

A Shoulder to Cry On – Update on Sports Injury Management
Dr Dennis Ng
Orthopaedic Surgeon
MBBS (NUS, Singapore)

Dr Dennis Ng

Orthopaedic Surgeon

MBBS (NUS, Singapore)

Profile

Dr Ng Zhaowen Dennis obtained his medical degree (MBBS) from the National University of Singapore in 2007 and was awarded Dean’s List in AY2003/04. He obtained his Masters of Medicine in Orthopaedic Surgery in 2013. In 2015, he received the Gold Medal Award for being the top candidate in the Fellowship of the Royal College of Surgeons Examination (FRCSEd Orth). Dr Dennis Ng was awarded the Human Manpower Development Plan scholarship from the Ministry of Health and underwent subspecialty training at the Fowler Kennedy Sports Medicine Centre, Ontario, Canada. He has managed sports injuries and treated professional athletes in North America.

Dr Dennis Ng is a Consultant Orthopaedic Surgeon with more than 14 years of clinical experience and specialises in the treatment of shoulder, knee and sports injury. He was the Deputy Head of the Shoulder Elbow Division and a member of the Sports Medicine Division in National University Hospital before moving on to private practice. Common conditions that he treats include frozen shoulder, rotator cuff tears, shoulder impingement, shoulder dislocation and instability, shoulder arthritis, upper limb fractures, tennis elbow, as well as knee conditions such as knee cartilage injury, ligament tears (ACL), meniscus tears and knee arthritis.

Dr Dennis Ng is experienced in minimally invasive techniques for better surgical outcomes and reduced downtime. Patients include national athletes for sports such as basketball, soccer, judo, rugby, rock climbing and cycling etc.

Abstract

Shoulder injuries are frequently caused by activities that involve excessive, repetitive, overhead motion, such as swimming and weightlifting. These can occur due to overtraining, lack of conditioning, and improper form or technique.

Most problems in the shoulder involve the muscles, ligaments, and tendons, rather than the bones. In this talk, we discuss the shoulder injuries that are commonly encountered, including management principles from the primary care setting to specialist intervention, as well as ways to prevent such injuries.

Figuring Out the Common Head and Neck Lumps – A GP Update
Dr Thomas Ho
General Surgeon
MBBS (U of Sydney, Australia),
MMed (Surg)(NUS, Singapore),
FRCSEd (Gen Surg),
FAMS (General Surgery),
FSSO (USA)

Dr Thomas Ho

General Surgeon

MBBS (U of Sydney, Australia),
MMed (Surg) (NUS, Singapore,
FRCSEd (Gen Surg),
FAMS (General Surgery),
FSSO (USA)

Profile

Dr Thomas Ho is a general surgeon practising in Gleneagles Hospital. He has a special interest in head and neck surgery, treating oral, thyroid and salivary gland masses as well as cervical lymphadenopathy. Dr Ho also specialises in treating advanced abdominal cancers particularly colorectal and ovarian cancers that have spread to the peritoneal lining. He provides treatments such as cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

He is also available to see elective and emergency general surgical conditions such as piles, inguinal/ventral hernia and provides endoscopy services such as gastroscopy and colonoscopy.

Prior to private practice, Dr Ho was the chief of service at Tan Tock Seng Hospital and concurrently, the chief of surgery for Woodlands Health Campus. He remains a visiting consultant with both hospitals.

Abstract

Head and neck lumps are very common in the community. The diagnoses range from benign lumps that can be left well alone to malignant lumps that should be removed before they lead to disfigurement, loss of function or death. This talk will provide an overview of the common diagnoses and the approach to be taken both at the GP and specialist level.

Keeping up With the New Normal in Lung Cancer
Dr Chin Tan Min
Medical Oncologist
MBBS (Singapore),
MRCP (United Kingdom),
FRCP (United Kingdom)

Dr Chin Tan Min

Medical Oncologist

MBBS (Singapore),
MRCP (United Kingdom),
FRCP (United Kingdom)

Profile

Dr Chin Tan Min is a Senior Consultant, Medical Oncologist at Parkway Cancer Centre. Dr Chin’s area of expertise and interest is in lung cancers, in addition to general oncology. She graduated from the National University of Singapore (MBBS) in 1997, and completed her internal medicine and oncology training at National University Hospital (NUH). In 2006, she was awarded the Singapore Government Health Manpower Development Programme (HMDP) fellowship to pursue further sub-specialisation training in thoracic oncology with a clinical and research fellowship at the Massachusetts General Hospital Cancer Centre, USA.

Prior to private practice, Dr Chin was practising as a senior consultant at the National University Cancer Institute at NUH, and visiting consultant at Ng Teng Fong Hospital till 2017. Her commitment to patient care has been recognised by Spring’s excellent service award. In addition, she contributes her expertise in thoracic oncology in various Ministry of Health (MOH) committees, formulating guidelines on screening and treatment for lung cancers. She is also advisory member for lung cancer for Singapore Cancer Society, and has been involved in educational talks for the public. She was core faculty for the oncology senior residency program at National University Health System (NUHS).

Dr Chin is the Principal Associate at the Cancer Science Institute of Singapore, where she continues her current research. She is member of American Society of Clinical Oncology, American Association for Cancer Research and the International Association of Lung Cancer.

With a keen and active interest in translational and clinical research to better patient care, she has conducted numerous international industry sponsored and investigator initiated clinical trials as principal and co-investigator. She has received grants from the National Medical Research Council and Research Training Initiative for Scientific Enhancement (RISE) Grant Scheme Award to support her research. Her work has been published in peer-reviewed, high impact factor journals such as Nature, Nature Medicine and Journal of Clinical Oncology. Specifically, she has contributed to the development of EGFR mutation detection test/kit in lung cancers, in both tumour and blood.

Abstract

The treatment of cancer has advanced in leaps and bounds over the past 10-20 years. It has moved from being a dreaded illness, to becoming more of a chronic illness. Due to the many treatment advancements, patients now have a better chance of survival, even when diagnosed advanced cancers.

This talk aims to briefly cover the “new normal in lung cancer”. This includes keeping up with the many novel medications available for treatment for lung cancer. The main modalities of systemic treatment such as chemotherapy, immunotherapy and / or targeted treatment will also be discussed. Other topics which will be covered include how technology has enabled oncologists to determine the molecular make-up of the cancer, hence allowing the most appropriate cancer treatment depending on the molecular driver of the cancer. Lastly, the talk will discuss how advancements in treatment have resulted in better survival for lung cancer patients.

Panel Q&A Discussion

Moderator

Dr Arthur Tseng,

Obstetrician & Gynaecologist

MBChB Honours (Sheffield, UK),
MRCOG (London, UK)

Moderator

Dr Victor Lee,

General Surgeon

MBBS (Melbourne),
FRCS (Edinburgh),
MMed (Surgery),
MSc (Bioinformatics),
FAMS (General Surgery)

Gold Sponsor